Notably, the discrepancy of function experiments upon MAPK/ERK blocking in vitro and in vivo might be ascribed to the inactivation of MAPK/ERK pathway accompanied by dual inhibition of self-renewal and proliferative activity in LLC-SD cells for tumor expansion. This evidence concerns the gene MAPK1 and neoplasm.